MetaCap

ADC Therapeutics SA (ADCT) vs Vogenx (VOGX)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

ADC Therapeutics SA is the larger company by market cap ($180.0 million vs $176.3 million), about 1.0 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ADCT+4.07%VOGX-8.69%
+172%+70%-31%
Aug 12, 20261 yearNov 20, 2026
ADCT+26.73%VOGX-19.69%
+137%+55%-27%
Aug 10, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ADCT versus VOGX key metrics
MetricADCTVOGX
Share price$1.28$11.87
Market cap$180.05M$176.33M
1-day change-1.54%-7.30%
YTD return-63.74%—
1-year return-68.16%—
5-year return-94.23%—
EPS (TTM)$-0.46$-0.89
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$81.36M—
Revenue growth (YoY)+14.85%—
Net income (latest FY)$-142.62M—
Gross margin92.87%—
Operating margin-149.34%—
Net margin-175.31%—
52-week high$4.98$38.41
52-week low$0.78$11.51
Distance from 52-week high-74.30%-69.10%
Analyst consensusbuystrong_buy
Avg. price target upside+160.16%+363.35%
Average volume1.55M128.78K
Shares outstanding140.66M14.86M
Employees1884
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About ADC Therapeutics SA

ADCT stock →

ADC Therapeutics SA provides antibody drug conjugate (ADC) technology platform in Switzerland and the United States. Its flagship product includes ZYNLONTA, a CD19-directed ADC, received accelerated approval from the U.S.

Health Care · Biotechnology: Pharmaceutical Preparations · 188 employees

About Vogenx

VOGX stock →

Vogenx, Inc. operates as a clinical-stage drug development company that develops therapeutics for metabolic including post-bariatric hypoglycemia, or PBH, and gastroparesis.

Health Care · Biotechnology: Pharmaceutical Preparations · 4 employees

ADCT vs VOGX FAQ

Which is bigger, ADC Therapeutics SA or Vogenx?

ADC Therapeutics SA (ADCT) is larger, with a market capitalization of $180.05M compared with $176.33M for Vogenx (VOGX).

Are ADC Therapeutics SA and Vogenx in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons